4507.T
4507.T
JP3347200002
SHIONOGI & CO
Loading chart...

Company Profile

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.

Related stocks

4523.T
4523.T • Japan
EISAI CO LTD
4,603 JPY
8.21B USD 1Y -2.4%
4151.T
4151.T • Japan
KYOWA KIRIN CO LTD
2,222.5 JPY
7.35B USD 1Y -5.9%
000538.SZ
000538.SZ • China
YUNNAN BAIYAO
51.4 CNY
13.72B USD 1Y -10.4%
688506.SS
688506.SS • China
SICHUAN BIOKIN PHARMACEUTICAL C
229.33 CNY
14.17B USD 1Y -37.4%
TORNTPHARM.NS
TORNTPHARM.NS • India
TORRENT PHARMACEUTICALS L
4,656.9 INR
18.3B USD 1Y +29.4%
CIPLA.NS
CIPLA.NS • India
CIPLA LTD
1,301 INR
10.86B USD 1Y -14%
4502.T
4502.T • Japan
TAKEDA PHARMACEUTICAL CO LTD
5,843 JPY
58.98B USD 1Y +34.8%
002001.SZ
002001.SZ • China
NHU
26.58 CNY
12.22B USD 1Y +6.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
27.3% p.a.
Max Drawdown (5Y)
-31.0%
Sharpe Ratio (5Y)
-0.03
Beta Factor
0.07
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende